Purpose We aimed to investigate if cancer patients’ information needs decrease during radiotherapy and if so, which patient, consultation and radiation oncologist char-acteristics are associated with a decrease in information needs over time. Methods In this longitudinal study, patients (n=104

Abstract not found

r3 do 5 eld tine, and prednisone (R-CHOP). Rituximab improves both event-free and overall survival in patients with spective analysis from MD Anderson suggested that con-solidation RT also improves outcomes in patients of all Dorth et al. Radiation Oncology 2012, 7:100

. Because this problem is NP-hard, we do not attempt to nd an exact solution{instead we will employ a successive linearization algorithm based on [9] to nd a stationary point of this problem. We begin in Section 2 by describing the radiotherapy planning problem and presenting a detailed explanation of a

to obtain dose to water that do not take account of chamber-to-chamber variation. Other good reasons for implementing the new codes are that they are conceptually simpler, include improved physical data and improve the consistency for various ionisation chamber types as well as between different beam types

analysed, with a minimum follow up of 60 months. Results: 68 patients underwent APR, mean age was 65 years. Pre-operative radiotherapy was given in 29 (43%) patients. There was 2.9 % in-hospital mortality (n=2). 20.6 % (n=14) had a circumferential resection margin (CRM)?1mm. There were 4 intra

Abstract To the objective of this study is to evaluate the role and toxicity of radiotherapy in the treatment of Graves ophthalmopathy. In the years 2000–2003, 121 patients with malignant exophthalmos were treated with radiotherapy of the retrobulbar area to the total dose of 20 Gy in ten fractions

a radioterapia de intensidade modulada. A radioterapia conformal permite o ajuste dos múltiplos feixes de radiação a ̀ forma do alvo tumoral. Con-siderando múltiplos feixes a ̀ volta de um isocentro e que cada feixe tem uma fluência uniforme, então o volume da sua intersecção sera ́ uma

New methodology, tools, and protocolized analysis are needed to advance individualized treatment paradigms in esophageal cancer Outcome prediction tools have the potential to provide clinicians and patients with practical decision aids in the diagnosis of cancer. Esophageal cancer often involves a multimodal approach. Ultimately, improvements in the reliability to predict pathologic stage based on clinical datasets are likely to be dependent on the feasibility to normalize and apply the currently available data while bringing to the clinical arena novel genetic and molecular assays. For now, pathologic complete response (pCR) is an often-used surrogate of response to combined modality therapy and a predictor of disease outcome. To that end, we commend the authors of ‘Clinical

or if the metastatic population is sufficiently large relative to the primary tumor. We also show that a novel schedule, SRCR, which splits the radiotherapy regimen into two disjoint portions, is optimal among all schedules, provided that the patient's dormant metastatic tumors do not become vascularized within